We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.76B
AUM Growth
+$874M
Cap. Flow
+$514M
Cap. Flow %
8.92%
Top 10 Hldgs %
19.98%
Holding
849
New
79
Increased
349
Reduced
299
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 12.89%
3 Industrials 10.07%
4 Financials 8.91%
5 Consumer Discretionary 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
126
Coca-Cola
KO
$383B
$11.8M 0.21%
196,593
+7,913
+4% +$492K
CNI icon
127
Canadian National Railway
CNI
$78.5B
$11.7M 0.2%
96,985
+218
+0.2% +$25.9K
ITCI
128
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11.7M 0.2%
184,921
-6,982
-4% -$435K
LOW icon
129
Lowe's Companies
LOW
$121B
$11.6M 0.2%
51,562
+11,891
+30% +$2.47M
INTC icon
130
Intel
INTC
$413B
$11.5M 0.2%
344,602
+51,808
+18% +$1.63M
ABT icon
131
Abbott
ABT
$187B
$11.4M 0.2%
104,975
+36,437
+53% +$3.88M
OCSL icon
132
Oaktree Specialty Lending
OCSL
$1.05B
$11.2M 0.19%
+578,028
New +$10.9M
DFAI
133
Dimensional International Core Equity Market ETF
DFAI
$17.1B
$11.2M 0.19%
409,925
-2,425
-0.6% -$66.4K
GOOS
134
Canada Goose Holdings
GOOS
$903M
$11.1M 0.19%
625,694
-17,448
-3% -$314K
SNOW icon
135
Snowflake
SNOW
$98.1B
$11.1M 0.19%
63,262
+207
+0.3% +$33.6K
SRPT icon
136
Sarepta Therapeutics
SRPT
$1.64B
$10.9M 0.19%
95,399
-2,146
-2% -$277K
BA icon
137
Boeing
BA
$169B
$10.9M 0.19%
51,417
+708
+1% +$147K
DDD icon
138
3D Systems Corp
DDD
$405M
$10.8M 0.19%
1,090,935
-37,491
-3% -$343K
GLW icon
139
Corning
GLW
$107B
$10.8M 0.19%
309,067
-3,158
-1% -$104K
IWM icon
140
iShares Russell 2000 ETF
IWM
$79.1B
$10.8M 0.19%
57,412
-6,235
-10% -$1.11M
UNP icon
141
Union Pacific
UNP
$174B
$10.7M 0.19%
52,487
+19,473
+59% +$3.87M
ACN icon
142
Accenture
ACN
$106B
$10.7M 0.19%
34,678
+557
+2% +$162K
NXPI icon
143
NXP Semiconductors
NXPI
$60.8B
$10.3M 0.18%
50,138
-276
-0.5% -$49K
CRNC icon
144
Cerence
CRNC
$359M
$10.2M 0.18%
348,530
+47,637
+16% +$1.31M
PANW icon
145
Palo Alto Networks
PANW
$256B
$10.1M 0.18%
79,386
+7,870
+11% +$819K
PPLI
146
People Inc
PPLI
$3.12B
$10M 0.17%
194,871
-7,122
-4% -$326K
MDC
147
DELISTED
M.D.C. Holdings, Inc.
MDC
$10M 0.17%
+213,955
New +$8.91M
BWXT icon
148
BWX Technologies
BWXT
$14.4B
$9.93M 0.17%
+138,756
New +$9.07M
DUHP icon
149
Dimensional US High Profitability ETF
DUHP
$12.1B
$9.91M 0.17%
373,265
+42,700
+13% +$1.08M
SBGI icon
150
Sinclair Inc
SBGI
$1.02B
$9.8M 0.17%
708,898
-28,773
-4% -$475K

Similar funds

Pinnacle Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Pinnacle Associates held 849 positions worth $5.76B, up 18% from $4.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates deployed $514M of net new capital in Q2 2023, opening 79 new positions and adding to 349 existing holdings. Its largest new stake was ProShares S&P MidCap 400 Dividend Aristocrats ETF: 209,119 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $7.29M trimmed.

  • Pinnacle Associates's largest Q2 2023 buy was ProShares S&P MidCap 400 Dividend Aristocrats ETF: 209,119 shares worth $14.7M.
  • Pinnacle Associates added most to Xylem in Q2 2023, an estimated $50.2M increase.
  • Pinnacle Associates's biggest Q2 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $7.29M.
  • Pinnacle Associates fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $51.8M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $5.76B portfolio in Q2 2023.
  • Pinnacle Associates opened 79 new positions and closed 36 in Q2 2023.
  • Pinnacle Associates's portfolio value rose 18% quarter-over-quarter to $5.76B.

Based on Pinnacle Associates's 13F filing for Q2 2023, filed 27 Jul 2023.